The four-part series published by Diabetic Medicine on the prevalence and costs of diabetes in the UK, ably summarized in the accompanying and trenchant commentary by Gale [1], is a valuable illustration of the insights that can be obtained from interrogation of essentially routine administrative ...
This review outlines its use in the treatment of type 2 diabetes. The main mechanisms ... N.,Papanas,E.,... - 《Clinical Medicine Therapeutics》 被引量: 14发表: 2009年 Cost-effectiveness Study of Antidiabetic Drugs in Type 2 Diabetes Mellitus Patients From Mumbai, India Diabetes is fast...
Qayyum,Rehan - 《Annals of Internal Medicine》 被引量: 161发表: 2008年 Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin nave type 2 diabetes patients: cost... OBJECTIVES: To evaluate the long-term clinical and cost outcome...
Communication with the patients’ physicians to support their treatment plans was an important element of the intervention. Physicians were notified when patients enrolled in the program, and they were sent periodic clinical progress reports and alert reports. The program had the added feature of timin...
The findings of this study suggest that robust generic and biosimilar competition could reduce prices to more affordable levels and enable expansion of diabetes treatment globally. Introduction While the burden of diabetes is increasing worldwide, health systems are faced with unaffordable medicine prices...
Results The simulation model estimates that the intervention does reduce discounted lifetime treatment and complication costs by $3385, but this is more than offset by the $ 15 031 cost of implementing the intervention and maintaining its effects in subsequent years. The intervention is estimated to...
To assess the cost-effectiveness of dapagliflozin, a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, compared with a sulfonylurea, when added to metfor... M Charokopou,P Mcewan,S Lister,... - 《Diabetic Medicine》 被引量: 26发表: 2015年 Dapagliflozin (Forxiga) Versus Glipizide As Add...
Health care providers should consider discussing bariatric surgery in the treatment of obese patients with type 2 diabetes. Health insurers, private and public, should pay for bariatric surgery for appropriate candidates, recognizing a potential annualized cost savings in addition to the benefit to ...
Type 2 diabetes mellitus (T2DM) is a chronic disease with high-cost treatment. This study aimed to analyze the cost-effectiveness of T2DM treatment in hospitalized patients with complications of kidney and peripheral vascular disease (PVD) in Indonesia b
Even if you change your lifestyle and take your medicine as directed, your blood sugar may still get worse over time. That doesn’t mean you’ve done something wrong. Diabetes is progressive, and many people eventually need more than one drug. ...